# A Phase II Trial of Afatinib in Patients With Metastatic or Recurrent Squamous Cell Carcinoma of Esophagus

> **NCT02353936** · PHASE2 · UNKNOWN · sponsor: **Yonsei University** · enrollment: 30 (actual)

## Conditions studied

- Squamous Cell Carcinoma of Esophagus

## Interventions

- **DRUG:** BIBW2992

## Key facts

- **NCT ID:** NCT02353936
- **Lead sponsor:** Yonsei University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-01
- **Primary completion:** 2020-01
- **Final completion:** 2020-01
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2019-02-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02353936

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02353936, "A Phase II Trial of Afatinib in Patients With Metastatic or Recurrent Squamous Cell Carcinoma of Esophagus". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02353936. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*